These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8609905)

  • 1. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
    Rousseau G; Nantel F; Bouvier M
    Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors.
    Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE
    Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
    Nantel F; Bonin H; Emorine LJ; Zilberfarb V; Strosberg AD; Bouvier M; Marullo S
    Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
    Bouvier M; Hnatowich M; Collins S; Kobilka BK; Deblasi A; Lefkowitz RJ; Caron MG
    Mol Pharmacol; 1988 Feb; 33(2):133-9. PubMed ID: 2828911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor.
    Tepe NM; Liggett SB
    J Recept Signal Transduct Res; 2000 Jan; 20(1):75-85. PubMed ID: 10711498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
    Granneman JG; Lahners KN; Zhai Y
    Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
    Weitl N; Seifert R
    J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
    Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
    J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
    Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
    Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
    Clark RB; Allal C; Friedman J; Johnson M; Barber R
    Mol Pharmacol; 1996 Jan; 49(1):182-9. PubMed ID: 8569705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers.
    Lavoie C; Hébert TE
    Can J Physiol Pharmacol; 2003 Feb; 81(2):186-95. PubMed ID: 12710533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
    Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
    Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
    Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
    Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
    Hillman KL; Doze VA; Porter JE
    J Pharmacol Exp Ther; 2005 Aug; 314(2):561-7. PubMed ID: 15908513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional alpha 2-adrenergic receptor-Gs coupling undergoes agonist-promoted desensitization in a subtype-selective manner.
    Eason MG; Liggett SB
    Biochem Biophys Res Commun; 1993 May; 193(1):318-23. PubMed ID: 8099284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
    Proll MA; Clark RB; Butcher RW
    Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists.
    Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW
    Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
    Chidiac P; Nouet S; Bouvier M
    Mol Pharmacol; 1996 Sep; 50(3):662-9. PubMed ID: 8794908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.